MXPA03004775A - Proceso para preparacion de acido 1-(aminometil) ciclohexano acetico . - Google Patents
Proceso para preparacion de acido 1-(aminometil) ciclohexano acetico .Info
- Publication number
- MXPA03004775A MXPA03004775A MXPA03004775A MXPA03004775A MXPA03004775A MX PA03004775 A MXPA03004775 A MX PA03004775A MX PA03004775 A MXPA03004775 A MX PA03004775A MX PA03004775 A MXPA03004775 A MX PA03004775A MX PA03004775 A MXPA03004775 A MX PA03004775A
- Authority
- MX
- Mexico
- Prior art keywords
- gabapentin
- process according
- hydrochloride
- amine
- solvent
- Prior art date
Links
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 title claims abstract description 94
- 238000000034 method Methods 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title description 5
- 229960002870 gabapentin Drugs 0.000 claims abstract description 45
- XBUDZAQEMFGLEU-UHFFFAOYSA-N 2-[1-(aminomethyl)cyclohexyl]acetic acid;hydron;chloride Chemical compound Cl.OC(=O)CC1(CN)CCCCC1 XBUDZAQEMFGLEU-UHFFFAOYSA-N 0.000 claims abstract description 22
- 150000001412 amines Chemical class 0.000 claims abstract description 21
- 239000002904 solvent Substances 0.000 claims abstract description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims abstract description 14
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000001556 precipitation Methods 0.000 claims abstract description 8
- 238000006243 chemical reaction Methods 0.000 claims abstract description 6
- 238000004090 dissolution Methods 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 235000019441 ethanol Nutrition 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- KFZMGEQAYNKOFK-UHFFFAOYSA-N isopropyl alcohol Natural products CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 claims description 8
- 125000005233 alkylalcohol group Chemical group 0.000 claims description 6
- -1 amine hydrochloride Chemical class 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 239000003125 aqueous solvent Substances 0.000 claims description 4
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 claims description 4
- 238000004821 distillation Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 3
- 238000002955 isolation Methods 0.000 claims description 3
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- 150000003951 lactams Chemical class 0.000 claims description 2
- 239000002244 precipitate Substances 0.000 claims description 2
- 238000011141 high resolution liquid chromatography Methods 0.000 claims 1
- 239000000243 solution Substances 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- MNNMTFSPSVOWSF-UHFFFAOYSA-N dicyclohexylazanium;chloride Chemical compound Cl.C1CCCCC1NC1CCCCC1 MNNMTFSPSVOWSF-UHFFFAOYSA-N 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 208000014644 Brain disease Diseases 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- FRQONEWDWWHIPM-UHFFFAOYSA-N n,n-dicyclohexylcyclohexanamine Chemical compound C1CCCCC1N(C1CCCCC1)C1CCCCC1 FRQONEWDWWHIPM-UHFFFAOYSA-N 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- SATVIFGJTRRDQU-UHFFFAOYSA-N potassium hypochlorite Chemical compound [K+].Cl[O-] SATVIFGJTRRDQU-UHFFFAOYSA-N 0.000 description 1
- ORQYPOUSZINNCB-UHFFFAOYSA-N potassium;hypobromite Chemical compound [K+].Br[O-] ORQYPOUSZINNCB-UHFFFAOYSA-N 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/38—Separation; Purification; Stabilisation; Use of additives
- C07C227/40—Separation; Purification
- C07C227/42—Crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2000MI002608A IT1319674B1 (it) | 2000-12-01 | 2000-12-01 | Processo per la preparazione dell'acido1-(aminometil)cicloesanacetico. |
| PCT/EP2001/013953 WO2002044123A1 (en) | 2000-12-01 | 2001-11-29 | A process for the preparation of 1-(aminomethyl) cyclohexaneacetic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03004775A true MXPA03004775A (es) | 2004-12-03 |
Family
ID=11446165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03004775A MXPA03004775A (es) | 2000-12-01 | 2001-11-29 | Proceso para preparacion de acido 1-(aminometil) ciclohexano acetico . |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7393974B2 (enExample) |
| EP (1) | EP1347951B1 (enExample) |
| JP (1) | JP2004521875A (enExample) |
| AT (1) | ATE339400T1 (enExample) |
| AU (2) | AU2002229575B2 (enExample) |
| BR (1) | BR0115755A (enExample) |
| CA (1) | CA2436908A1 (enExample) |
| DE (1) | DE60123125T2 (enExample) |
| ES (1) | ES2271102T3 (enExample) |
| HR (1) | HRP20030438A2 (enExample) |
| HU (1) | HU228047B1 (enExample) |
| IL (2) | IL156185A0 (enExample) |
| IT (1) | IT1319674B1 (enExample) |
| MX (1) | MXPA03004775A (enExample) |
| NZ (1) | NZ526370A (enExample) |
| PL (1) | PL361886A1 (enExample) |
| RU (1) | RU2289572C2 (enExample) |
| WO (1) | WO2002044123A1 (enExample) |
| ZA (1) | ZA200304484B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004046084A1 (en) | 2002-11-18 | 2004-06-03 | Nicholas Piramal India Limited | Improved process for preparation of gabapentin |
| PT1603863E (pt) | 2002-11-20 | 2010-02-05 | Hikal Ltd | Processo para a preparação de ácidos amino-metil-cicloalcano-acéticos |
| WO2004093780A2 (en) | 2003-04-21 | 2004-11-04 | Matrix Laboratories Ltd | Process for the preparation of gabapentin form-ii |
| EP1636163A4 (en) * | 2003-05-19 | 2006-08-09 | Shasun Chemicals And Drugs Ltd | PROCESS FOR THE PREPARATION OF GABAPENTIN |
| ITMI20042418A1 (it) * | 2004-12-17 | 2005-03-17 | Zambon Spa | Processo per la purificazione della gabapentina |
| US7071356B1 (en) | 2005-12-01 | 2006-07-04 | Isp Investments Inc. | Process for the preparation of 1-(aminomethyl) cyclohexaneacetic acid |
| WO2009015685A1 (en) | 2007-07-27 | 2009-02-05 | Medichem, S.A. | Method for preparing polymorph form ii of gabapentin |
| EP2368872A1 (en) | 2010-03-25 | 2011-09-28 | Serichim S.r.l. | Process for the preparation of Gabapentin |
| ITMI20131757A1 (it) | 2013-10-22 | 2015-04-23 | Zach System Spa | Processo di preparazione di gabapentina |
| EP3018131A1 (en) * | 2014-11-07 | 2016-05-11 | Bayer Pharma Aktiengesellschaft | Synthesis of copanlisib and its dihydrochloride salt |
| EP3018127A1 (en) * | 2014-11-07 | 2016-05-11 | Bayer Pharma Aktiengesellschaft | Synthesis of copanlisib and its dihydrochloride salt |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2460891C2 (de) * | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US4960931A (en) * | 1988-05-02 | 1990-10-02 | Warner-Lambert Company | Gabapentin mohohydrate and a process for producing the same |
| DE3928184A1 (de) * | 1989-08-25 | 1991-02-28 | Goedecke Ag | Verfahren zur herstellung von cyclischen aminosaeurederivaten sowie zwischenprodukte |
| FI905584A7 (fi) * | 1989-11-16 | 1991-05-17 | Lonza Ag | Menetelmä 1-(aminometyyli)sykloheksaanietikkahapon valmistamiseksi |
| US6255526B1 (en) * | 1996-12-24 | 2001-07-03 | Teva Pharmaceutical Industries Ltd. | Preparation of gabapentin |
| IL119890A (en) * | 1996-12-24 | 2002-03-10 | Teva Pharma | Gabapentin form iii and preparation of gabapentin form ii |
-
2000
- 2000-12-01 IT IT2000MI002608A patent/IT1319674B1/it active
-
2001
- 2001-11-28 HU HU0302642A patent/HU228047B1/hu unknown
- 2001-11-29 ES ES01990454T patent/ES2271102T3/es not_active Expired - Lifetime
- 2001-11-29 AU AU2002229575A patent/AU2002229575B2/en not_active Ceased
- 2001-11-29 EP EP01990454A patent/EP1347951B1/en not_active Expired - Lifetime
- 2001-11-29 RU RU2003119451/04A patent/RU2289572C2/ru not_active IP Right Cessation
- 2001-11-29 AU AU2957502A patent/AU2957502A/xx active Pending
- 2001-11-29 BR BR0115755-8A patent/BR0115755A/pt not_active IP Right Cessation
- 2001-11-29 WO PCT/EP2001/013953 patent/WO2002044123A1/en not_active Ceased
- 2001-11-29 IL IL15618501A patent/IL156185A0/xx active IP Right Grant
- 2001-11-29 MX MXPA03004775A patent/MXPA03004775A/es active IP Right Grant
- 2001-11-29 NZ NZ526370A patent/NZ526370A/en unknown
- 2001-11-29 DE DE60123125T patent/DE60123125T2/de not_active Expired - Fee Related
- 2001-11-29 AT AT01990454T patent/ATE339400T1/de not_active IP Right Cessation
- 2001-11-29 JP JP2002546493A patent/JP2004521875A/ja active Pending
- 2001-11-29 HR HR20030438A patent/HRP20030438A2/hr not_active Application Discontinuation
- 2001-11-29 PL PL36188601A patent/PL361886A1/xx not_active Application Discontinuation
- 2001-11-29 CA CA002436908A patent/CA2436908A1/en not_active Abandoned
- 2001-11-29 US US10/433,241 patent/US7393974B2/en not_active Expired - Fee Related
-
2003
- 2003-05-28 IL IL156185A patent/IL156185A/en not_active IP Right Cessation
- 2003-06-09 ZA ZA200304484A patent/ZA200304484B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20030438A2 (en) | 2004-08-31 |
| RU2289572C2 (ru) | 2006-12-20 |
| IT1319674B1 (it) | 2003-10-23 |
| US7393974B2 (en) | 2008-07-01 |
| WO2002044123A1 (en) | 2002-06-06 |
| PL361886A1 (en) | 2004-10-04 |
| US20050049432A1 (en) | 2005-03-03 |
| JP2004521875A (ja) | 2004-07-22 |
| HUP0302642A2 (hu) | 2003-11-28 |
| ITMI20002608A1 (it) | 2002-06-01 |
| DE60123125T2 (de) | 2007-03-01 |
| AU2002229575B2 (en) | 2006-12-07 |
| CA2436908A1 (en) | 2002-06-06 |
| EP1347951B1 (en) | 2006-09-13 |
| IL156185A0 (en) | 2003-12-23 |
| ATE339400T1 (de) | 2006-10-15 |
| ZA200304484B (en) | 2004-09-09 |
| DE60123125D1 (de) | 2006-10-26 |
| IL156185A (en) | 2008-08-07 |
| EP1347951A1 (en) | 2003-10-01 |
| HU228047B1 (en) | 2012-09-28 |
| BR0115755A (pt) | 2003-12-30 |
| HUP0302642A3 (en) | 2010-01-28 |
| NZ526370A (en) | 2003-08-29 |
| ES2271102T3 (es) | 2007-04-16 |
| AU2957502A (en) | 2002-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2839344B2 (ja) | 環状アミノ酸、並びにその中間体の製造方法 | |
| MXPA03004775A (es) | Proceso para preparacion de acido 1-(aminometil) ciclohexano acetico . | |
| EP0024210B1 (en) | Process for the production of optically active threo-3-(3,4-dihydroxyphenyl) serine, and product thus produced | |
| AU2002229575A1 (en) | A process for the preparation of 1-(aminomethyl) cyclohexaneacetic acid | |
| US6518456B1 (en) | Process for the production of 1-(aminomethyl)-cyclohexyl-acetic acid in pure form | |
| US6846950B2 (en) | Process for synthesis of 1-(aminomethyl)cyclohexane acetic acid hydrochloride | |
| CA2570833C (en) | Process for producing (z)-1-phenyl-1-diethylaminocarbonyl-2-aminomethylcyclopropane hydrochloride | |
| US7071356B1 (en) | Process for the preparation of 1-(aminomethyl) cyclohexaneacetic acid | |
| CA2506563C (en) | An improved process for the preparation of amino methyl cyclo alkane acetic acids | |
| US3931308A (en) | Process for conversion of lysine dihydrochloride to lysine monohydrochloride | |
| CN100475774C (zh) | D-（+）-或l-（-）-酒石酸或其衍生物作为dl-麻黄碱或其衍生物的拆分剂及其拆分方法 | |
| JP3316917B2 (ja) | 新規フェニルアラニン塩結晶とその製造法 | |
| EP1069109B1 (en) | Process for production of optically active N-protected-N-methyl-phenylalanine derivative | |
| JP2770512B2 (ja) | アミノエチルスルホン酸アルカリ金属塩類の精製方法 | |
| CN105612145B (zh) | 制备加巴喷丁的方法 | |
| JP2856331B2 (ja) | ２，２‐ジアミノ‐１，１‐ビナフチルの製造法 | |
| WO2004110342A2 (en) | Novel polymorph of gabapentin and its conversion to gabapentin form-ii | |
| CN100391932C (zh) | L-（-）-酒石酸或其衍生物作为拆分dl-麻黄碱或其衍生物的拆分剂及其拆分方法 | |
| KR20090010546A (ko) | 가바펜틴의 제조 방법 및 중간체 | |
| JPS6213936B2 (enExample) | ||
| JPH06107602A (ja) | 光学活性１−フェニルエチルアミンの製造法 | |
| JPH06345737A (ja) | ナファゾリンまたはその塩の製造方法 | |
| HK1131968A (en) | Process for preparing gabapentin | |
| JPH06100502A (ja) | 光学活性１−（１−ナフチル）エチルアミンの製造法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |